Stay updated on Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Sign up to get notified when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide notice says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434 and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:22:22.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:11:54.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier advanced from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:06:29.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A 403 Forbidden message and a Home link appear in place of the study content, indicating the study record could not be displayed.
    Difference
    0.5%
    Check dated 2026-10-04T20:56:48.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The site now serves the standard study details page after previously displaying a 403 Forbidden error. The erroneous 403 content and the Home link were removed, restoring access to the trial information.
    Difference
    0.5%
    Check dated 2026-09-27T22:07:45.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The Study Record page now displays a 403 Forbidden error instead of the study content. This change replaces the detailed content with a standard error page and removes the previously listed study information.
    Difference
    22%
    Check dated 2026-09-20T19:25:50.000Z thumbnail image

Stay in the know with updates to Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dose Ranging Study of GSK1265744 Plus NRTIs in HIV-1 Clinical Trial page.